Filter Lifespan in Continuous Renal Replacement Therapy

Recruiting now

Conditions studied: Critically Ill, Continuous Renal Replacement Therapy, Infections

In brief

The only supportive therapy for patients with AKI is renal replacement therapy (RRT). In the ICU setting, continuous RRT (CRRT) is mostly favored. In a post-hoc analysis of the RICH trial (regional citrate versus systemic heparin anticoagulation for CRRT in critically ill patient with AKI), it was shown that the filter life span is associated with an increased rate of new infection and that the type of anticoagulants did not directly affect infection rate. The mechanisms of this infection rate is unknown.

Key facts

Study ID
NCT05450185
Run by
University Hospital Muenster
People needed
600
Starts
2023-03-02
Expected to finish
2025-08-01
Last updated by the study team
2024-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.